BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chawan-Saad J, Wu M, Wu A, Wu L. Corticosteroids for Diabetic Macular Edema. Taiwan J Ophthalmol 2019;9:233-42. [PMID: 31942428 DOI: 10.4103/tjo.tjo_68_19] [Cited by in Crossref: 8] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Soleimani AA, Mohammadi A, Ghasempour G, Abkenar BR, Shokri N, Najafi M. Dexamethasone suppresses the proliferation and migration of VSMCs by FAK in high glucose conditions. BMC Pharmacol Toxicol 2022;23:63. [PMID: 35978346 DOI: 10.1186/s40360-022-00604-3] [Reference Citation Analysis]
2 Al Qassimi N, Kozak I, Al Karam M, Neri P, Aduriz-Lorenzo PM, Attawan A, Awadalla M, El Khashab A, Abdul-Nabi M, Safar A, Al Shamsi H, Rao P, Rao M, Farid A, Gurbaxani A; Emirates Society of Ophthalmology. Management of Diabetic Macular Edema: Guidelines from the Emirates Society of Ophthalmology. Ophthalmol Ther 2022. [PMID: 35896888 DOI: 10.1007/s40123-022-00547-2] [Reference Citation Analysis]
3 Chauhan MZ, Rather PA, Samarah SM, Elhusseiny AM, Sallam AB. Current and Novel Therapeutic Approaches for Treatment of Diabetic Macular Edema. Cells 2022;11:1950. [PMID: 35741079 DOI: 10.3390/cells11121950] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ben-arzi A, Ehrlich R, Neumann R. Retinal Diseases: The Next Frontier in Pharmacodelivery. Pharmaceutics 2022;14:904. [DOI: 10.3390/pharmaceutics14050904] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Markan A, Neupane S, Agrawal R, Gupta V. Newer therapeutic agents for retinal diseases. Expert Review of Ophthalmology. [DOI: 10.1080/17469899.2022.2030709] [Reference Citation Analysis]
6 Bikbov MM, Zainullin RM, Kudoyarova KI, Kalanov MR. [Efficacy of intravitreal dexamethasone implant as a starting monotherapy and when switching from an anti-VEGF drug in diabetic macular edema]. Vestn Oftalmol 2021;137:5-11. [PMID: 34965061 DOI: 10.17116/oftalma20211370615] [Reference Citation Analysis]
7 Liao M, Huang Y, Wang J, Meng X, Liu Y, Yu J, Yan H. Long-term outcomes of administration of intravitreal triamcinolone acetonide after posterior vitreous detachment during pars plana vitrectomy for proliferative diabetic retinopathy. Br J Ophthalmol 2021:bjophthalmol-2021-320332. [PMID: 34844917 DOI: 10.1136/bjophthalmol-2021-320332] [Reference Citation Analysis]
8 Rousou C, Schuurmans CCL, Urtti A, Mastrobattista E, Storm G, Moonen C, Kaarniranta K, Deckers R. Ultrasound and Microbubbles for the Treatment of Ocular Diseases: From Preclinical Research towards Clinical Application. Pharmaceutics 2021;13:1782. [PMID: 34834196 DOI: 10.3390/pharmaceutics13111782] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
9 Sun C, Zhou J, Meng X. Primary cilia in retinal pigment epithelium development and diseases. J Cell Mol Med 2021;25:9084-8. [PMID: 34448530 DOI: 10.1111/jcmm.16882] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
10 Figueira J, Henriques J, Carneiro Â, Marques-Neves C, Flores R, Castro-Sousa JP, Meireles A, Gomes N, Nascimento J, Amaro M, Silva R. Guidelines for the Management of Center-Involving Diabetic Macular Edema: Treatment Options and Patient Monitorization. Clin Ophthalmol 2021;15:3221-30. [PMID: 34354341 DOI: 10.2147/OPTH.S318026] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
11 Mateos-Olivares M, García-Onrubia L, Valentín-Bravo FJ, González-Sarmiento R, Lopez-Galvez M, Pastor JC, Usategui-Martín R, Pastor-Idoate S. Rho-Kinase Inhibitors for the Treatment of Refractory Diabetic Macular Oedema. Cells 2021;10:1683. [PMID: 34359853 DOI: 10.3390/cells10071683] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Bux AV, Fortunato F, Barone A, Russo V, Delle Noci N, Iaculli C. Early treatment with dexamethasone intravitreal implants in diabetic macular edema: Naïve versus refractory patients. Eur J Ophthalmol 2021;:11206721211024804. [PMID: 34120496 DOI: 10.1177/11206721211024804] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Filippelli M, Campagna G, Vito P, Zotti T, Ventre L, Rinaldi M, Bartollino S, dell'Omo R, Costagliola C. Anti-inflammatory Effect of Curcumin, Homotaurine, and Vitamin D3 on Human Vitreous in Patients With Diabetic Retinopathy. Front Neurol 2020;11:592274. [PMID: 33633656 DOI: 10.3389/fneur.2020.592274] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Yang YH, Hsu WC, Hsieh YT. Anterior Migration of Triamcinolone Acetonide after Posterior Subtenon Injection for Macular Edema Predisposes to Intraocular Pressure Elevation. Curr Eye Res 2021;46:689-93. [PMID: 32985270 DOI: 10.1080/02713683.2020.1826979] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Elbarky AM. Rapid Structural and Functional Improvements with the 0.19 mg Fluocinolone Acetonide Intravitreal Implant for Patients with DME and Low Visual Acuity: 6-Month Data from the UAE. Clin Ophthalmol 2020;14:823-30. [PMID: 32214793 DOI: 10.2147/OPTH.S238740] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]